| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Secora Michael is a Chief Financial Officer at RECURSION PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 18 sells.
Estimated insider holdings value: $4.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 50,000 | $7.49 | $374,637.50 | -2.6% | +26.5% | -16.2% | |
| Nov 15, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 50,000 | $6.82 | $340,928.64 | -1.8% | +36.4% | -3.8% | |
| Oct 11, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 50,000 | $6.96 | $348,075.00 | -2.7% | +96.5% | -9.4% | |
| Sep 13, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 50,000 | $8.56 | $427,950.00 | -2.8% | -13.5% | -24.4% | |
| Aug 16, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 50,000 | $9.09 | $454,310.00 | -2.8% | -25.7% | -23.1% | |
| Jul 19, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 50,000 | $14.58 | $729,150.47 | -1.2% | -58.9% | -50.4% | |
| Jun 14, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Financial Officer | Sale+OE | 50,000 | $10.00 | $500,145.00 | -3.0% | -13.3% | -4.3% |